Dr. Shehryar Khaliqdina, MD

Dr. Khaliqdina practices at Rust Pmg Cardiology - HOPD in Rio Rancho, New Mexico.

Dr. Khaliqdina's NPI, 1033640784, was assigned on March 24, 2017. Dr. Khaliqdina graduated from Dow University of Health Sciences in 2013. Dr. Khaliqdina holds Texas license U2896.

Dr. Khaliqdina's primary practice is Rust Pmg Cardiology - HOPD, at 2400 Unser Blvd SE, Rio Rancho, NM 87124.

Dr. Khaliqdina's primary practice is Rust Pmg Cardiology - HOPD in Rio Rancho, New Mexico. Dr. Khaliqdina is also affiliated with John Peter Smith Hospital. The medical group on file is Sound Physicians. Dmand AI also links Dr. Khaliqdina to 2 more hospitals, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khaliqdina practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Khaliqdina's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Khaliqdina is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Khaliqdina's licenses on file in 4 states: Texas, Oklahoma, New Mexico and Connecticut.

Dmand AI lists acute diabetes, acute respiratory failure, anemia, chest trauma, circulation problems, circulatory problems in extremities, congestive heart failure and electrolyte disorders among the conditions Dr. Khaliqdina treats.

CMS data shows 373 Medicare services from Dr. Khaliqdina across 5 procedure codes in 2024, for 204 Medicare patients. Medicare paid $32,660 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 204 Medicare patients who saw Dr. Khaliqdina in 2024. The largest group is 75 to 84, with 72 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Khaliqdina's median patient age at 62, with 44% women.

In 2024, Dr. Khaliqdina wrote 381 Medicare Part D claims for 131 patients. 89% of them were for generic drugs. CMS names the drug for 128 of them, across 7 drugs with 11 or more claims each, at $1,496 in total drug cost. In 2023, CMS named 479 claims across 23 drugs.

Dr. Khaliqdina accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Khaliqdina, published from 2011 to 2019. 2016 was the busiest year, with 2. Dr. Khaliqdina's most frequent co-authors are Vineet Kumar Gupta, MD, Vineet Gupta, MD and Mariana J. Kaplan, MD.

CMS Open Payments shows 6 general payments to Dr. Khaliqdina from 3 drug and device companies from 2022 to 2024. Food and beverage make up the largest share, 100% of the total. Philips Electronics North America Corporation paid the most, $66.

Dr. Khaliqdina graduated from Dow University of Health Sciences in 2013.

Dr. Khaliqdina is in network with 15 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Aetna. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.